EleftheriosPMamounasMD

Breast, Surgical Oncology (Other than Breast)

Professor of Surgery, Northeast Ohio Medical University

Dr. Mamounas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2501 N Orange Ave
Ste 389
Orlando, FL 32804
Phone+1 407-303-5214

Fax+1 407-909-6944

Fluorescence Imaging of Carcinoma During Breast Conserving Surgery Start of enrollment: 2021 Apr 27
Recruiting
Phase 3
Roles: Principal Investigator

PubMed

105 citations
Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
B Fisher, Jong-Hyeon Jeong, James J. Dignam, Stewart J. Anderson, Eleftherios P. Mamounas
Journal of the National Cancer Institute. Monographs. 2001-12-01
3931 citations
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer
The New England Journal of Medicine. 2005-10-20
257 citations
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from Nation...
B Fisher, Stewart J. Anderson, D L Wickerham, Arthur DeCillis, Nikolay V. Dimitrov
Journal of Clinical Oncology. 1997-05-01

Journal Articles

21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast Cancer
Eleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic Era
Eleftherios Mamounas, MD, Nature

Lectures

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...
2019 ASCO Annual Meeting - 6/1/2019
NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
Do Trials Results Conflict for Extended AI in Breast Cancer?December 8th, 2016
Conversations with Oncology Investigators Bridging the Gap Between Research and Patient CareDecember 26th, 2007
Join now to see all